Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Global Blood Therapeutics, Inc. (GBT)
Sector: Healthcare; Industry: Biotechnology

Global Blood Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities. It is developing its lead product candidate, Oxbryta (voxelotor) tablets, an oral, once-daily therapy for sickle cell disease (SCD). The company is evaluating Oxbryta that has completed Phase III clinical trial in adult and adolescent patients with SCD. The company has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD) and beta thalassemia.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-10-05 Fink Eric Chief Human Resources Officer Sell 4,532 $60.00 $271,920 No
2020-08-20 CATHERS BRIAN EDWIN Chief Scientific Officer Sell 2,200 $63.77 $140,294 No
2020-08-05 Fink Eric Chief Human Resources Officer Sell 2,454 $69.62 $170,851 No
2020-07-13 Farrow Jeffrey S Chief Financial Officer Sell 15,208 $75.00 $1,140,600 No
2020-06-19 Svoronos Dawn Director Sell 2,544 $63.94 $162,663 Yes
2020-06-09 Farrow Jeffrey S Chief Financial Officer Sell 15,208 $67.00 $1,018,936 No
2020-05-26 Calhoun Lesley Ann nan Sell 2,700 $70.10 $189,270 Yes
2020-05-18 Calhoun Lesley Ann See Remarks Sell 23,330 $74.67 $1,742,051 Yes
2020-05-12 Calhoun Lesley Ann See Remarks Sell 3,373 $78.23 $263,868 No
2020-05-12 PERRY MARK L Director Sell 53,600 $78.10 $4,186,061 Yes
2020-04-28 LOVE TED W See Remarks Sell 42,817 $80.06 $3,427,974 No
2020-04-20 SUVARI TRICIA BORGA Chief Legal Officer Sell 4,080 $75.00 $306,000 No
2020-03-13 Brown Willie L. Jr. Director Buy 10,000 $52.37 $523,700 No
2020-03-09 Lehrer-Graiwer Joshua Chief Medical Officer Sell 2,076 $62.86 $130,498 Yes
2020-02-18 Lehrer-Graiwer Joshua Chief Medical Officer Sell 1,313 $69.71 $91,529 Yes
2020-02-18 LOVE TED W See Remarks Sell 4,007 $70.54 $282,660 No
2020-02-10 Lehrer-Graiwer Joshua Chief Medical Officer Sell 4,562 $72.14 $329,089 Yes
2020-02-03 Lehrer-Graiwer Joshua Chief Medical Officer Sell 3,845 $63.75 $245,133 Yes
2020-02-03 SUVARI TRICIA BORGA Chief Legal Officer Sell 1,308 $62.81 $82,155 Yes
2020-01-27 Lehrer-Graiwer Joshua Chief Medical Officer Sell 781 $71.15 $55,568 Yes
2020-01-22 LOVE TED W See Remarks Sell 80,000 $81.96 $6,557,148 No
2020-01-02 SUVARI TRICIA BORGA Chief Legal Officer Sell 1,308 $79.78 $104,352 No
2019-12-11 Pizzo Philip A. Director Sell 30,000 $76.57 $2,297,228 Yes
2019-12-09 Lehrer-Graiwer Joshua Chief Medical Officer Sell 937 $78.50 $73,554 Yes
2019-12-06 LOVE TED W See Remarks. Sell 80,000 $76.04 $6,082,805 No
2019-12-02 SUVARI TRICIA BORGA Chief Legal Officer Sell 3,434 $66.74 $229,185 No
2019-11-26 Lehrer-Graiwer Joshua Chief Medical Officer Sell 22,523 $63.70 $1,434,734 Yes
2019-11-19 Lehrer-Graiwer Joshua Chief Medical Officer Sell 7,218 $54.60 $394,123 Yes
2019-11-15 Lehrer-Graiwer Joshua Chief Medical Officer Sell 10,277 $50.00 $513,901 Yes
2019-11-01 SUVARI TRICIA BORGA Chief Legal Officer Sell 3,327 $48.45 $161,192 No

Insider Smart

CARNIVAL CORP (CCL) - Cruislines $CCL $NCLH $RCL took a huge beat due to the pandemic, concerns of bankruptcy were raised. Among the three dominating companies in the industry, $CCL is the first one bought by insiders, such a bold move would definitely boost investor confidence.

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.